Polar Capital Holdings PLC Supernus Pharmaceuticals, Inc. Transaction History

Polar Capital Holdings PLC

$17.4 Billion
Q2 2025

A detailed history of Polar Capital Holdings PLC transactions in Supernus Pharmaceuticals, Inc. stock. As of the latest transaction made, Polar Capital Holdings PLC holds 1,002,340 shares of SUPN stock, worth $41.3 Million. This represents 0.18% of its overall portfolio holdings.

Number of Shares

1,002,340

Previous 1,362,340 26.43%

Holding current value

$41.3 Million

Previous $44.6 Million 29.19%

% of portfolio

0.18%

Previous 0.3%

15 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2025 Aug 14, 2025	SELL	$30.29 - $33.43 $10.9 Million - $12 Million	-360,000 Reduced 26.43%	1,002,340 $31.6 Million
Q1 2025 May 15, 2025	SELL	$31.17 - $40.0 $10.1 Million - $13 Million	-325,590 Reduced 19.29%	1,362,340 $44.6 Million
Q4 2024 Feb 14, 2025	SELL	$31.89 - $37.83 $7.97 Million - $9.46 Million	-250,000 Reduced 12.9%	1,687,930 $61 Million
Q3 2024 Nov 14, 2024	SELL	$25.77 - $35.16 $66,486 - $90,712	-2,580 Reduced 0.13%	1,937,930 $60.4 Million
Q1 2024 May 15, 2024	BUY	$27.11 - $35.17 $31,040 - $40,269	1,145 Added 0.06%	1,940,510 $66.2 Million
Q4 2023 Feb 14, 2024	BUY	$22.72 - $29.68 $6.47 Million - $8.46 Million	284,895 Added 17.22%	1,939,365 $56.1 Million
Q3 2023 Nov 14, 2023	BUY	$27.57 - $32.91 $4.14 Million - $4.94 Million	150,000 Added 9.97%	1,654,470 $45.6 Million
Q2 2023 Dec 13, 2023	BUY	$29.91 - $38.73 $3.5 Million - $4.53 Million	117,055 Added 8.44%	1,504,470 $45.2 Million
Q2 2023 Aug 14, 2023	BUY	$29.91 - $38.73 $3.5 Million - $4.53 Million	117,055 Added 8.44%	1,504,470 $45.2 Million
Q1 2023 Dec 13, 2023	SELL	$34.93 - $42.03 $9.33 Million - $11.2 Million	-267,055 Reduced 16.14%	1,387,415 $50.3 Million
Q1 2023 May 15, 2023	BUY	$34.93 - $42.03 $12.9 Million - $15.5 Million	368,295 Added 36.14%	1,387,415 $50.3 Million
Q4 2022 Feb 14, 2023	BUY	$31.09 - $37.88 $7 Million - $8.52 Million	225,000 Added 28.33%	1,019,120 $36.4 Million
Q2 2022 Aug 15, 2022	SELL	$25.33 - $34.25 $2.12 Million - $2.87 Million	-83,825 Reduced 9.55%	794,120 $23 Million
Q1 2022 May 16, 2022	BUY	$28.51 - $32.9 $7.13 Million - $8.23 Million	250,000 Added 39.81%	877,945 $28.4 Million
Q4 2021 Feb 14, 2022	BUY	$26.37 - $34.22 $16.6 Million - $21.5 Million	627,945 New	627,945 $18.3 Million

Others Institutions Holding SUPN

# of Institutions

311

Shares Held

61.6M

Call Options Held

11.4K

Put Options Held

View Full List

About SUPERNUS PHARMACEUTICALS, INC.

Ticker SUPN
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 53,495,300
Market Cap $2.21B
Description
Supernus Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the development and commercialization of products for the treatment of central nervous system (CNS) diseases in the United States. Its commercial products are Trokendi XR, an extended release topiramate product indicated for the treatment of epilepsy, as well as for the prop...

More about SUPN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Polar Capital Holdings PLC, based on Form 13F filings with the SEC.

News

Stay updated on Polar Capital Holdings PLC with notifications on news.

Account

Polar Capital Holdings PLC Supernus Pharmaceuticals, Inc. Transaction History